Mural Oncology plc [MURA] stock prices are up 15.52% to $3.87 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MURA shares have gain 15.18% over the last week, with a monthly amount glided 10.26%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Mural Oncology plc [NASDAQ: MURA] stock has seen the most recent analyst activity on June 28, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $15. Previously, Morgan Stanley started tracking the stock with Overweight rating on April 04, 2024, and set its price target to $13.
The stock price of Mural Oncology plc [MURA] has been fluctuating between $2.88 and $6.25 over the past year. Mural Oncology plc [NASDAQ: MURA] shares were valued at $3.87 at the most recent close of the market.
Analyzing the MURA fundamentals
Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at -61.47%, Pretax Profit Margin comes in at -57.98%, and Net Profit Margin reading is -58.74%. To continue investigating profitability, this company’s Return on Assets is posted at -0.76, Equity is -0.7 and Total Capital is -0.9.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.67 points at the first support level, and at 3.48 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.16, and for the 2nd resistance point, it is at 4.46.
Ratios To Look Out For
It’s worth pointing out that Mural Oncology plc [NASDAQ:MURA]’s Current Ratio is 7.38. Further, the Quick Ratio stands at 7.38, while the Cash Ratio is 4.46.
Transactions by insiders
Recent insider trading involved Goodman Vicki L, Officer, that happened on Nov 07 ’24 when 5069.0 shares were purchased. Chief Medical Officer, Goodman Vicki L completed a deal on Nov 07 ’24 to sell 5069.0 shares. Meanwhile, Officer Cutler Adam D. bought 7421.0 shares on Oct 31 ’24.
